Tuberculosis trends in the United States, 1992-2001

Tuberculosis

Volumn 83, Issue 1-3, 2003, Pages 21-29

  Schneider, E ^a   Castro, K G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BCG VACCINE; ISONIAZID; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SENSITIVITY; EPIDEMIC; FINANCIAL MANAGEMENT; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 0038182170     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(02)00075-6     Document Type: Conference Paper

References (58)

1. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States. MMWR 1989;38(S-3):1-25.
2. Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. J Am Med Assoc 1994;272(7):535-9.
3. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-9.
4. Snider DE, Roper WL. The new tuberculosis. J Am Med Assoc 1992;326(10):703-5.
5. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis 1991;144:741-2.
6. Brown RE, Miller B, Taylor WR, et al. Health-care expenditures for tuberculosis in the United States. Arch Intern Med 1995;155:1595-600.
7. US Congress, Office of Technology Assessment (OTA). The continuing challenge of tuberculosis. Pub. No. OTA-H-574, Washington, DC, 1993.
8. McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995;332:1071-6.
9. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. J Am Med Assoc 1992;268(10):1280-6.
10. Centers for Disease Control and Prevention. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida, New York, 1988-1991. MMWR 1991;40(34):585-91.
11. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514-21.
12. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
13. Dooley SW, Villarino ME, Lawrence M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. J Am Med Assoc 1992;267:2632-5.
14. Jereb JA, Klevens M, Privett TD, et al. Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med 1995;155:854-9.
15. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Intern Med 1992;117:191-6.
16. Valway SE, Greifinger RB, Papania M, et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infec Dis 1994;170:151-6.
17. Centers for Disease Control and Prevention. Drug-resistant tuberculosis among the homeless-Boston. MMWR 1985;34(28):429-31.
18. Centers for Disease Control and Prevention. Tuberculosis among residents of shelters for the homeless - Ohio, 1990. MMWR 1991;40(50):869-871, 877.
19. Centers for Disease Control and Prevention. Outbreak of multidrug-resistant tuberculosis - Texas, California, and Pennsylvania. MMWR 1990;39(22):369-72.
20. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992;326:231-5.
21. Centers for Disease Control and Prevention. National action plan to combat multidrug-resistant tuberculosis. MMWR 1992;41 (RR-11):1-30.
22. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2001. Atlanta, GA: US Department of Health and Human Services, September 2002.
23. Binkin NJ, Vernon AA, Simone PM, et al. Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services. Int J Tuberc Lung Dis 1999;3(8):663-74.
24. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995;333:229-33.
25. McKenna MT, McCray E, Jones JL, Onorato IM Castro KG. The fall after the rise: tuberculosis in the United States, 1991 through 1994. Am J Pub Health 1998;88:1059-63.
26. Centers for Disease Control and Prevention. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR 1999;48(RR-9):1-13.
27. Moore M, McCray E, Onorato IM. Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994. Pub Health Rep 1999;114:269-77.
28. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with HIV: principles of therapy and revised recommendations. MMWR 1998;47(RR-20):1-58.
29. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(RR-6):1-54.
30. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. J Am Med Assoc 1994;271:665-71.
31. Moore M, Onorato IM, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the United States, 1993-1996. J Am Med Assoc 1997;278:833-7.
32. Frieden TR, Fine Sherman L, Lay Maw K, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. J Am Med Assoc 1996;276:1229-35.
33. Agerton T, Valway S, Gore B, et al. Transmission of a highly drug-resistant strain (Strain W1) of Mycobacterium tuberculosis. J Am Med Assoc 1997;278:1073-7.
34. Agerton TB, Valway SE, Blinkhorn R J, et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis 1999;29:85-92.
35. Bloch AB, Simone PM, McCray E, Castro KG. Preventing multidrug-resistant tuberculosis. J Am Med Assoc 1996;275:487-9.
36. Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. J Am Med Assoc 2000;284:2894-900.
37. Centers for Disease Control and Prevention. Tuberculosis among foreign-born persons who had recently arrived in the United States-Hawaii, 1992-1993, and Los Angeles County, 1993. MMWR 1995;44(38):703-7.
38. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. J Am Med Assoc 1997;278:304-7.
39. Wells CD, Zuber PL, Nolan CM, Binkin NJ, Goldberg SV. Tuberculosis prevention among foreign-born persons in Seattle-King County, Washington. Am J Respir Crit Care Med 1997;156(2):573-7.
40. World Health Organization. TB - a global emergency. WHO, TB Programme, Geneva, Switzerland, 1994; WHO/TB/94.177: p. 1-28.
41. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MG for the WHO Global Surveillance and Monitoring Project. Global burden of tuberculosis. J Am Med Assoc 1999;282:677-86.
42. Centers for Disease Control and Prevention. Preventing and controlling tuberculosis along the US-Mexico border. MMWR 2002;50(RR-1):1-28.
43. US-Mexico Border Health Commission. Proceedings from the United States-Mexico Binational TB Workshop, El Paso, Texas, October 14-16, 2001.
44. Centers for Disease Control and Prevention. Progressing toward tuberculosis elimination in low-incidence areas of the United States. MMWR 2002;51(RR-5):1-14.
45. Manangan LP, Moore M, Pratt R, Navin T. Epidemiology of tuberculosis in the southeastern United States. Poster Presentation at the American Thoracic Society Meeting, Atlanta, GA, May 17-22, 2002.
46. Rothel JS, Jones SL, Corner LA, Cox JC, Wood PR. A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust Vet J 1990;67:134-7.
47. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon-gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. J Am Med Assoc 2001;286:1740-7.
48. Woods GL. The mycobacteriology laboratory and new diagnostic techniques. Inf Dis Clin N Am 2002;16:127-45.
49. van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 2001;249:1-26.
50. Braden CR. Current concepts in Mycobacterium tuberculosis DNA fingerprinting. Infec Dis Clin Pract 1997;6:89-95.
51. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull WHO 2002;80:477-82.
52. The Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002;360:528-34.
53. Small PM, McClenny NB, Singh SP, Schloonik GK, Tompkins LS, Mickelsen PA. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol 1993;31:1677-82.
54. Braden CR, Templeton GL, Stead WW, Bates JH, Cave MD, Valway SE. Retrospective detection of laboratory cross-contamination of Mycobacterium tuberculosis cultures with use of DNA fingerprint analysis. Clin Infec Dis 1997;24:35-40.
55. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. N Engl J Med 1994;330:1703-9.
56. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR 2000;49(RR-4):1-14.
57. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States, Geiter L (Ed.), Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention, Institute of Medicine. Nat Acad Sci 2000:1-269.
58. Centers for Disease Control and Prevention. CDC's response to ending neglect: the elimination of tuberculosis in the United States. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention 2002. p. 1-60.